Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Heart Test Laboratories, Inc. ( (HSCS) ) has provided an update.
On September 16, 2025, HeartSciences Inc. announced that it has regained compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement, following a previous notice of non-compliance. The company had submitted a plan to Nasdaq to regain compliance and was granted an extension, which has now led to the closure of the matter by Nasdaq.
The most recent analyst rating on (HSCS) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.
Spark’s Take on HSCS Stock
According to Spark, TipRanks’ AI Analyst, HSCS is a Neutral.
Heart Test Laboratories, Inc. is facing significant financial challenges, with substantial losses and declining revenue impacting its financial performance. Technical analysis shows mixed signals, with bearish momentum and lack of strong upward trends. The valuation is poor, with a negative P/E ratio and no dividend yield, indicating struggles in delivering shareholder value. These factors contribute to a low overall stock score.
To see Spark’s full report on HSCS stock, click here.
More about Heart Test Laboratories, Inc.
Average Trading Volume: 126,470
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.74M
For an in-depth examination of HSCS stock, go to TipRanks’ Overview page.